Table 2.
Characteristics of patients and PCLs detected by MRI from 2009 to 2016
| Characteristics | |
|---|---|
| Age (years), median (range) | 62 (25–85) |
|
|
|
| Sex (M/F), n (%) | 101 (45.3)/122 (54.7) |
|
|
|
| Single/Multiple, n (%) | 158 (70.8)/65 (29.2) |
|
|
|
| Communication to PD, n (%) | 103 (46.2) |
|
|
|
| Presence of septa, n (%) | 86 (38.6) |
|
|
|
| Location, n (%) | |
| Uncinate | 17 (7.6) |
| Head | 55 (24.7) |
| Neck | 36 (16.1) |
| Body | 70 (31.4) |
| Tail | 45 (20.2) |
|
|
|
| Follow-up period (months), median (range) | 43 (24–151) |
|
|
|
| Presence of history of malignant tumors (Yes/No), n (%) | 70 (31.4)/153 (68.6) |
|
|
|
| Initial size (mm), median (range) | 12 (3–29) |
|
|
|
| Final size (mm), median (range) | 12 (0–40) |
PCL, pancreatic cystic lesion; MRI, magnetic resonance imaging; SD, standard deviation; M/F, male/female; PD, pancreatic duct.